Rani, A.; Kaur, R.; Aldahish, A.; Vasudevan, R.; Balaji, P.; Dora, C.P.; Chandrasekaran, B.; Singh, T.G.; Sharma, R.
Nanostructured Lipid Carriers (NLC)-Based Topical Formulation of Hesperidin for Effective Treatment of Psoriasis. Pharmaceutics 2025, 17, 478.
https://doi.org/10.3390/pharmaceutics17040478
AMA Style
Rani A, Kaur R, Aldahish A, Vasudevan R, Balaji P, Dora CP, Chandrasekaran B, Singh TG, Sharma R.
Nanostructured Lipid Carriers (NLC)-Based Topical Formulation of Hesperidin for Effective Treatment of Psoriasis. Pharmaceutics. 2025; 17(4):478.
https://doi.org/10.3390/pharmaceutics17040478
Chicago/Turabian Style
Rani, Anita, Rajwinder Kaur, Afaf Aldahish, Rajalakshimi Vasudevan, Prasanalakshmi Balaji, Chander Parkash Dora, Balakumar Chandrasekaran, Thakur Gurjeet Singh, and Rahul Sharma.
2025. "Nanostructured Lipid Carriers (NLC)-Based Topical Formulation of Hesperidin for Effective Treatment of Psoriasis" Pharmaceutics 17, no. 4: 478.
https://doi.org/10.3390/pharmaceutics17040478
APA Style
Rani, A., Kaur, R., Aldahish, A., Vasudevan, R., Balaji, P., Dora, C. P., Chandrasekaran, B., Singh, T. G., & Sharma, R.
(2025). Nanostructured Lipid Carriers (NLC)-Based Topical Formulation of Hesperidin for Effective Treatment of Psoriasis. Pharmaceutics, 17(4), 478.
https://doi.org/10.3390/pharmaceutics17040478
